PDSB - PDS Biotechnology Corp

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 3.27

Open

$ 3.26

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 3.22 - $ 3.38

52 Week Range

$ 2.59 - $ 10.27

Volume

415,645

Average Volume

Market Cap

101.21M

Beta (5Y Monthly)

$ 1.59

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-28-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-14-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	03-28-2023	12-31-2022	10-K
6	11-14-2022	09-30-2022	10-Q
7	08-08-2022	06-30-2022	10-Q
8	05-11-2022	03-31-2022	10-Q
9	03-31-2022	12-31-2021	10-K
10	11-10-2021	09-30-2021	10-Q
11	08-12-2021	06-30-2021	10-Q
12	05-13-2021	03-31-2021	10-Q
13	03-18-2021	12-31-2020	10-K
14	11-13-2020	09-30-2020	10-Q
15	08-13-2020	06-30-2020	10-Q
16	05-13-2020	03-31-2020	10-Q
17	03-27-2020	12-31-2019	10-K
18	11-07-2019	09-30-2019	10-Q
19	08-01-2019	06-30-2019	10-Q
20	05-14-2019	03-31-2019	10-Q
21	02-21-2019	12-31-2018	10-K
22	11-01-2018	09-30-2018	10-Q
23	08-01-2018	06-30-2018	10-Q
24	05-01-2018	03-31-2018	10-Q
25	03-01-2018	12-31-2017	10-K
26	11-01-2017	09-30-2017	10-Q
27	08-01-2017	06-30-2017	10-Q
28	05-03-2017	03-31-2017	10-Q
29	03-02-2017	12-31-2016	10-K
30	11-01-2016	09-30-2016	10-Q
31	08-03-2016	06-30-2016	10-Q
32	05-03-2016	03-31-2016	10-Q
33	03-08-2016	12-31-2015	10-K
34	11-06-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

PDS Biotech To Event To Discuss Positive,...
04/23/2024 12:01:45

Company to Host Key Opinion Leader Event on May 8 at 1:30pm ET to Discuss Updated Results of VERSATILE-002, Unmet Treatment Nee...

B. Riley Securities Reiterates Buy on PDS ...
03/28/2024 16:00:13

B. Riley Securities analyst Kalpit Patel reiterates PDS Biotechnology (NASDAQ:PDSB) with a Buy and lowers the price target f...

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
03/27/2024 16:31:07

HC Wainwright & Co. Maintains Buy on PDS B...
03/27/2024 14:28:41

HC Wainwright & Co. analyst Joseph Pantginis maintains PDS Biotechnology (NASDAQ:PDSB) with a Buy and maintains $21 pric...

12-health-care-stocks-moving-in-wednesdays-pre-market-session

12 Health Care Stocks Moving In Wednesday'...
03/27/2024 13:05:57

PDS Biotechnology Q4 EPS $(0.35) Beats $(0...
03/27/2024 11:38:09

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0...

Earnings Scheduled For March 27, 2024
03/27/2024 09:02:44

Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on rev...

Earnings Preview For PDS Biotechnology
03/26/2024 16:01:42

PDS Biotech Announces Publication Of Precl...
03/13/2024 12:04:32

Preclinical research published in Vaccines demonstrates Infectimune® significantly improved quantity and quality of potent mult...

PDS Biotech Appoints Lars Boesgaard As Chi...
11/28/2023 12:32:55

Analyst Expectations for PDS Biotechnology...
11/15/2023 19:01:01

Oppenheimer Maintains Outperform on PDS Bi...
11/15/2023 18:20:21

Oppenheimer analyst Leland Gershell maintains PDS Biotechnology (NASDAQ:PDSB) with a Outperform and lowers the price target ...

Earnings Scheduled For November 14, 2023
11/14/2023 13:23:43

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

PDS Biotech Says Its Available Cash Resour...
11/14/2023 12:40:35

PDS Biotechnology: Q3 Earnings Insights
11/14/2023 12:35:05

PDS Biotechnology Q3 EPS $(0.35) Vs. $(0.2...
11/14/2023 12:32:33

PDS Biotechnology (NASDAQ:PDSB) reported quarterly losses of $(0.35) per share. This is a 34.62 percent decrease over losses of...

A Preview Of PDS Biotechnology's Earnings
11/13/2023 15:01:38

PDS Biotech Announces Updated Survival Dat...
11/09/2023 13:27:49

75% of immune checkpoint inhibitor (ICI) naïve patients remain alive at 36 months; published median overall survival (OS) in si...

PDS Biotech Announces Preliminary Biomarke...
10/23/2023 12:16:53

Combination of PDS0101 and KEYTRUDA® appears to lead to changes towards a TH1 predominant cytokine profile reported to be ass...

The Latest Analyst Ratings for PDS Biotech...
10/11/2023 17:00:44